Nederlands
English
About VIB
Currently selected
Science communication
Home
>
About VIB
>
Press
Refine
Theme
About VIB (92)
Arabidopsis (3)
Bioinformatics (11)
Biotech basics (1)
Cancer (68)
Cardiovascular medicine (11)
Cell biology (9)
Grand Challenges (2)
Immunology (31)
Inflammation and immunity (52)
Microbiology (21)
Model Organisms (4)
Mouse (2)
Neuroscience (58)
Plant biology (41)
Proteomics (5)
Research Areas (3)
Science ethics (2)
Structural biology (17)
Systems biology (2)
Yeast (1)
Category
BioInformatics Training and Service facility (1)
Business opportunities (8)
Developmental biology (1)
Event (8)
News (34)
Research services (5)
Page Content Zone 1
Press
Receive VIB press releases
Email updates
Follow us on Twitter
Like us on Facebook
RSS
Contact
For all press inquiries, contact
VIB
Tel.: +32 9 244 66 11
info@vib.be
Recent press releases
European Research Council grants: Good news for EU-LIFE centres, but with a bitter aftertaste
18 February 2015
EU-LIFE European research centres obtained 14 new ERC Starting and Consolidator grants in the latest competitions, which takes the total of ERC-funded grants currently running in centres belonging to the alliance to over 100.
Thank you, fruit flies, for that pleasing beer aroma
17 February 2015
Joaquin Christiaens, Kevin Verstrepen (VIB/KU Leuven), Luis Franco and Emre Yaksi (NERF, VIB/KU Leuven/imec), working together with Bassem Hassan (VIB/KU Leuven), have discovered why yeast makes aromatic compounds.
New insights into bacterial protein secretion
13 February 2015
Using X-ray crystallography, Parveen Goyal and Han Remaut (VIB/Vrije Universiteit Brussel) created a detailed three-dimensional image of the pores through which the curli building blocks cross the bacterial cell envelope.
4 ERC Consolidator Grants for VIB top scientists
12 February 2015
The European Research Council (ERC) has awarded another 4 VIB scientists!
ABMM Award for Delphine Bouhy and Jonathan Beats
29 January 2015
Delphine Bouhy and Jonathan Baets, post-doctoral scientists at the VIB Department of Molecular Genetics, University of Antwerp, were awarded a research grant by the Belgian Foundation for Neuromuscular Diseases (ABMM).
Sigma-Aldrich® and VIB Form Alliance to Provide Scientists with Enhanced and Faster Access to Novel Translational Research
22 January 2015
Alliance will leverage Sigma-Aldrich’s leading manufacturing and global distribution capabilities to provide accelerated access to VIB’s innovative research products, tools and technologies.
Quick scan science topics December 2014
13 January 2015
Sequence HEK293 cells available for entire research community
8 January 2015
The groups of Nico Callewaert (VIB/UGent), Yves Van de Peer (VIB/UGent) and Jan Tavernier (VIB/UGent) sequenced six HEK293 cell lines using whole-genome resequencing.
Stem cell research offers new insights into how dementia develops
5 January 2015
Researchers at KU Leuven and the Vlaams Instituut voor Biotechnologie (VIB) have succeeded in correcting a genetic mutation thought to cause frontotemporal dementia.
Interview with Brian Kobilka and Jan Steyaert
18 December 2014
Brian Kobilka shared the 2012 Nobel Prize in Chemistry with Robert Lefkowitz. A couple of months ago Kobilka was in Brussels to give a talk about his work on invitation of Jan Steyaert (VIB/Vrije Universiteit brussel).
Wake-up call for more research into cell metabolism
9 July 2014
New therapeutic avenues for diabetes, inflammatory conditions & cancer.
Do you feel the sport VIBes?
25 June 2014
VIB sport T-shirts are offered for everyone interested. These shirts can be used during several sports activities and events: from running, walking, cycling and even football and tennis.
The unfolded protein response controls the functioning of the immune system
21 April 2014
Fabiola Osorio, Simon Tavernier, Sophie Janssens and Bart Lambrecht (IRC – VIB / UGent) have shed light on how our immune system is influenced by the unfolded protein response (UPR).
VIB scientists find new strategy to combat bacterial infections
29 January 2014
Alvin Lo and Han Remaut (VIB/Vrije Universiteit Brussel) have identified a chemical substance with the potential of acting as a new drug to treat bacterial infections, particularly urinary tract infections.
Publish or perish
10 December 2013
Recently, the question has been raised whether or not scientific misconduct is on the rise and what the possible causes for it might be.
«Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
Next»
Page Content Zone 2
Page Content Zone 3